Monday, 20 May 2019

You are here

Sleep Apnea Increases Gout Risk

Both Gout and obstructive sleep apnea (OSA) comingle with a wide range of serious comorbidities. A matched retrospective cohort study from the UK Clinical Practice Research database shows those with OSA are at a higher risk of developing gout.

This report compared 15,879 patients with OSA versus 63,296 without; median follow‐up was 5.8 years.

Roughly 5% of OSA patients developed incident gout; half that many (2.6%) for those without OSA. The adjusted HR was 1.42 (95% CI 1.29–1.56).

For those who were overweight and obese, the risk of gout was highest 1–2 years after the index OSA date (HR 1.64).  For those with normal BMI, the highest significant HR (2.02) was at 2–5 years after the index date.

The converse association has also been shown by Singh and Cleveland. (Citation source: https://buff.ly/2BX2zvJ).

A Medicare population-based study found a two-fold increase risk of OSA in gout patients.  Based on a 5% sample of elderly patients they found higher rates of OSA in gout patients (14.3 per 1,000 person-years) versus 3.9 per 1,000 person-years in people without gout (HR 2.07; 95% confidence interval 2.00, 2.15).

The question is: does OSA lead to gout or does gout lead to OSA? Or, do the comorbidities of each (obesity, CAD, HTN, metabolic syndrome) augment the odds of either gout and OSA, especially in an aging population.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Coexistent Gout Increases Risk in Rheumatoid Arthritis

It his often said that gout and rheumatoid arthritis (RA) cannot coexist and where confusion exists, a good history and testing for serum urate (SUA) and rheumatoid factor (RF) can usually clarify the dominant disorders. A recent study shows that hyperuricemia and gout are uncommon in RA, but when present shows an increased risk of comorbidities and cardiovascular (CV) mortality.

Less Structural Damage with T2T in Gout

A two‐year randomized clinical trial has demonstrated that allopurinol dose escalation to a target serum urate (SU) results in less bone erosion, structural damage and urate crystal deposition in patients with gout.

Ideal Outcomes are Seldom Achieved in Gout

Studies from a cohort of gout patients in Mexico shows that long-term goals of a target serum urate (sUA) < 6 mg/dL and remission are rare, especially for those with severe gout.

Omega-3 Rich Fish Lowers Gout Flares

Boston researchers have shown that consumption of fish rich in omega‐3 polyunsaturated fatty acids (n‐3 PUFA) leads to a lower risk of recurrent gout flares.

Chronic Kidney Disease Augments Gout Risks

A population based cohort analysis shows that patients with incident gout and chronic kidney disease (CKD) have far worse outcomes than those without CKD.

A retrospective population-based cohort study of incident gout between 2006-2009 identified those with CKD; defined as a pre-existing diagnosis of chronic kidney disease, chronic renal failure, kidney transplantation, or dialysis at index date.